TITetsuro Izumi

Tetsuro Izumi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Tetsuro Izumi has a total of 42 co-authors. Here are the top co-authors by number of shared publications:

  • Hiroshi Gomi

    Department of Molecular Medicine, Institute for Molecular and Cellular Regulation, Gunma University, 3-39-15, Showa-machi, Maebashi 371-8512, Japan

    7 shared publications
  • Shin Mizutani

    Laboratory of Molecular Endocrinology and Metabolism, Department of Molecular Medicine, Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Japan

    6 shared publications
  • Kazuo Kasai

    Department of Molecular Medicine, Institute for Molecular and Cellular Regulation, Gunma University, 3-39-15, Showa-machi, Maebashi 371-8512, Japan

    5 shared publications
  • Toshiyuki Takeuchi

    Department of Molecular Medicine, Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Japan

    5 shared publications
  • Seiji Torii

    Department of Molecular Medicine, Institute for Molecular and Cellular Regulation, Gunma University, Maebashi 371-8512, Japan; and

    4 shared publications
  • Shengli Zhao

    Department of Molecular Medicine, Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Japan. 2Department of Biochemistry, Kyorin University School of Medicine, Mitaka, Japan. 3Department of Cell Physiology, National Institute for Physiological Sciences and the Graduate University of Advances Studies, Okazaki, Japan. 4Precursory Research for Embryonic Science and Technology, Japan Science and Technology Agency, Kawaguchi, Japan

    4 shared publications

Latest Publications

  • Open Access

    Activin Receptor-Like Kinase 7 Suppresses Lipolysis to Accumulate Fat in Obesity Through Downregulation of Peroxisome Proliferator–Activated Receptor γ and C/EBPα

    by Satomi Yogosawa, Shin Mizutani, Yoshihiro Ogawa, Tetsuro Izumi

    We previously identified a quantitative trait locus for adiposity, non-insulin-dependent diabetes 5 (Nidd5), on mouse chromosome 2. In the current study, we identified the actual genetic alteration at Nidd5 as a nonsense mutation of the Acvr1c gene encoding activin receptor-like kinase 7 (ALK7), one of the type I transforming growth factor-β receptors, which results in a COOH-terminal deletion of the kinase domain. We further showed that the ALK7 dysfunction causes increased lipolysis in adipocytes and leads to decreased fat accumulation. Conversely, ALK7 activation inhibits lipolysis by suppressing the expression of adipose lipases. ALK7 and activated Smads repress those lipases by downregulating peroxisome proliferator–activated receptor γ (PPARγ) and CCAAT/enhancer binding protein (C/EBP) α. Although PPARγ and C/EBPα act as adipogenic transcription factors during adipocyte differentiation, they are lipolytic in sum in differentiated adipocytes and are downregulated by ALK7 in obesity to accumulate fat. Under the obese state, ALK7 deficiency improves glucose tolerance and insulin sensitivity by preferentially increasing fat combustion in mice. These findings have uncovered a net lipolytic function of PPARγ and C/EBPα in differentiated adipocytes and point to the ALK7-signaling pathway that is activated in obesity as a potential target of medical intervention.


  • Open Access

    Loss of Granuphilin and Loss of Syntaxin-1A Cause Differential Effects on Insulin Granule Docking and Fusion

    by Hao Wang, Ray Ishizaki, Eri Kobayashi, Tomonori Fujiwara, Kimio Akagawa, Tetsuro Izumi


  • Open Access

    Exophilin8 transiently clusters insulin granules at the actin-rich cell cortex prior to exocytosis

    by Kouichi Mizuno, José S. Ramalho, Tetsuro Izumi

    Exophilin8/MyRIP/Slac2-c is an effector protein of the small GTPase Rab27a and is specifically localized on retinal melanosomes and secretory granules. We investigated the role of exophilin8 in insulin granule trafficking. Exogenous expression of exophilin8 in pancreatic β cells or their cell line, MIN6, polarized (exophilin8-positive) insulin granules at the cell corners, where both cortical actin and the microtubule plus-end–binding protein, EB1, were present. Mutation analyses indicated that the ability of exophilin8 to act as a linker between Rab27a and myosin Va is essential for its granule-clustering activity. Moreover, exophilin8 and exophilin8-associated insulin granules were markedly stable and immobile. Total internal reflection fluorescence microscopy indicated that exophilin8 restricts the motion of insulin granules at a region deeper than that where another Rab27a effector, granuphilin, accumulates docked granules directly attached to the plasma membrane. However, the exophilin8-induced immobility of insulin granules was eliminated upon secretagogue stimulation and did not inhibit evoked exocytosis. Furthermore, exophilin8 depletion prevents insulin granules from being transported close to the plasma membrane and inhibits their fusion. These findings indicate that exophilin8 transiently traps insulin granules into the cortical actin network close to the microtubule plus-ends and supplies them for release during the stimulation.


  • Heterogeneous modes of insulin granule exocytosis: molecular determinants

    by Tetsuro Izumi

    Glucose-induced insulin secretion is biphasic: the first phase forms a transient peak of secretion lasting a few minutes after the stimulation, whereas the second maintains a lower but persistent secretion rate. It was suggested that two different exocytic mechanisms operate during the two phases: the first phase exocytosis is derived from docked granules, whereas the second derives from newly recruited granules. However, total internal reflection fluorescence microscopy has revealed that, while the exocytosis in the first few minutes is derived from granules located close to the plasma membrane, it is also significantly effected by deeper granules, whereas that in the second phase is mainly derived from the deeper granules. Consistently, pancreatic beta cells deficient in the Rab27a effector, granuphilin, which is indispensable for the stable attachment (docking) of insulin granules to the plasma membrane, exhibit no delay or reduction of secretagogue-induced insulin secretion, and instead exhibit increased secretion. Future studies should explore the mechanism for time-dependent differences in the exocytic behaviors, namely the molecular determinants of the rate-limiting exocytic steps for docked and undocked granules.


    • 1 December 2008
      • Vol. 53, 2136-40

    [Exocytosis of insulin granules].

    by Tetsuro Izumi

  • Open Access

    Docking is not a Prerequisite but a Temporal Constraint for Fusion of Secretory Granules

    by Kazuo Kasai, Takuji Fujita, Hiroshi Gomi, Tetsuro Izumi

    We examined secretory granule dynamics using total internal reflection fluorescence microscopy in normal pancreatic β cells and their mutants devoid of Rab27a and/or its effector, granuphilin, which play critical roles in the docking and recruitment of insulin granules to the plasma membrane. In the early phase of glucose stimulation in wild‐type cells, we observed marked fusion of granules recruited from a relatively distant area, in parallel with that from granules located underneath the plasma membrane. Furthermore, despite a lack of granules directly attached to the plasma membrane, both spontaneous and evoked fusion was increased in granuphilin‐null cells. In addition to these granuphilin‐null phenotypes, Rab27a/granuphilin doubly deficient cells showed the decreases in granules located next to the docked area and in fusion from granules near the plasma membrane in the early phase of glucose‐stimulated secretion, similar to Rab27a‐mutated cells. Thus, the two proteins play nonoverlapping roles in insulin exocytosis: granuphilin acts on the granules underneath the plasma membrane, whereas Rab27a acts on those in a more distal area. These findings demonstrate that, in contrast to our conventional understanding, stable attachment of secretory granules to the plasma membrane is not prerequisite but temporally inhibitory for both spontaneous and evoked fusion.


  • Rab27b Is Expressed in a Wide Range of Exocytic Cells and Involved in the Delivery of Secretory Granules Near the Plasma Membrane

    by Hiroshi Gomi, Kenichi Mori, Shigeyoshi Itohara, Tetsuro Izumi

    Rab proteins regulate multiple, complex processes of membrane traffic. Among these proteins, Rab27a has been shown to function specifically in regulated exocytic pathways. However, the roles of Rab27b, another Rab27 subfamily member, have not been well characterized. We disrupted the Rab27b gene in mice. The targeting vector was designed to insert LacZ downstream of the initiation codon of the Rab27b gene so that the authentic promoter should drive this reporter gene. A comprehensive analysis of Rab27b expression using this mouse strain indicated that it is widely expressed not only in canonical secretory cells, but also in neurons and cells involved in surface protection and mechanical extension. To evaluate the function in pituitary endocrine cells where the isoform Rab27a is coexpressed, we generated Rab27a/Rab27b double knockout mice by crossing Rab27b knockout mice with Rab27a-mutated ashen mice. The polarized distribution of secretory granules close to the plasma membrane was markedly impaired in the pituitary of double knockout mice, indicating that the Rab27 subfamily is involved in the delivery of granules near the exocytic site. In conjunction with a phenotype having a pituitary devoid of the Rab27 effector granuphilin, we discuss the relationship between the residence and the releasable pool of granules.


  • Open Access

    Secretory vesicle docking to the plasma membrane: molecular mechanism and functional significance

    by T. Izumi, K. Kasai, H. Gomi

    In regulated exocytic pathways, secretion occurs only in the presence of appropriate stimuli. Professional secretory cells harbour specific storage organelles that release bioactive substances with both controlled timing and quantity in response to the strength and period of stimulation. Although each secretory organelle is highly differentiated in multicellular organisms, the basic regulatory mechanism is thought to be conserved. In most instances, the secretagogue increases the intracellular Ca 2+ concentration from the resting level of ∼100 nM to somewhere between ∼10 and 100 μM. Although Ca 2+ sensors of the final fusion reaction, such as synaptotagmin, have been investigated intensively in synaptic vesicle exocytosis, there are other preceding rate‐limiting steps influenced by Ca 2+ and other secretory signals, especially in the exocytosis of secretory granules whose time course is much slower than that of synaptic vesicles. The stable docking of secretory vesicles to the fusion site that is only seen in regulated exocytic pathways may represent one such critical step. Here, we review the molecular mechanism of docking, mainly based on recent findings on insulin granules in pancreatic β cells, and propose a new concept for its functional significance in regulated exocytosis.


  • Open Access

    A Subset of p23 Localized on Secretory Granules in Pancreatic β-cells

    by Masahiro Hosaka, Tsuyoshi Watanabe, Yoshio Yamauchi, Yuko Sakai, Masayuki Suda, Shin Mizutani, Toshiyuki Takeuchi, Toshiaki Isobe, Tetsuro Izumi

    Proteins on the membrane of secretory granules (SGs) involved in their biogenesis and exocytosis are poorly characterized compared with those of synaptic vesicle in neurons. Thus the secretory granule membrane was prepared from a mouse pancreatic β-cell line MIN6 by subcellular fractionation, and protein constituents were analyzed by microscale two-dimensional liquid chromatography coupled with electrospray ionization tandem mass spectrometry. Using this proteomics approach, one of the p24 family proteins, p23, was unexpectedly found in the granule fraction, although p24 proteins are generally regarded as functioning in the early secretory pathways between the endoplasmic reticulum and the Golgi apparatus. We further showed that p23 is expressed at high levels in endocrine cells. Furthermore, immunocytochemical analyses of pancreatic β-cells at the light and electron microscopic levels demonstrated that a significant amount of p23 is localized on the insulin granule membrane, although it is most intensely concentrated at the cis-Golgi compartment as previously shown in non-endocrine cells. These findings suggest that a fraction of p23 enters post-Golgi compartments and may function in the biogenesis and/or quality control of SGs.